Form 8-K - Current report:
SEC Accession No. 0001213900-21-004622
Filing Date
2021-01-27
Accepted
2021-01-27 16:15:09
Documents
9
Period of Report
2021-01-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea133853-8k_citius.htm 8-K 47312
2 FORM OF INVESTOR WARRANT ISSUED JANUARY 27, 2021 ea133853ex4-1_citius.htm EX-4.1 119403
3 FORM OF PLACEMENT AGENT WARRANT ISSUED JANUARY 27, 2021 ea133853ex4-2_citius.htm EX-4.2 99598
4 FORM OF REGISTRATION RIGHTS AGREEMENT, DATED JANUARY 24, 2021, BY AND BETWEEN CI ea133853ex4-3_citius.htm EX-4.3 136605
5 FORM OF SECURITIES PURCHASE AGREEMENT, DATED JANUARY 24, 2021, BY AND BETWEEN CI ea133853ex10-1_citius.htm EX-10.1 218543
6 ENGAGEMENT LETTER, DATED JANUARY 23, 2021, BETWEEN CITIUS PHARMACEUTICALS, INC. ea133853ex10-2_citius.htm EX-10.2 43165
7 PRESS RELEASE OF JANUARY 25, 2021 ea133853ex99-1_citius.htm EX-99.1 12004
8 PRESS RELEASE OF JANUARY 27, 2021. ea133853ex99-2_citius.htm EX-99.2 10158
9 GRAPHIC image_001.jpg GRAPHIC 14058
  Complete submission text file 0001213900-21-004622.txt   707698
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 21559904
SIC: 2834 Pharmaceutical Preparations